Fundraising FoxInnoCom Bio Equities
Venture capitalSan Francisco · Seed · 8 people tracked
Find your way into InnoCom Bio Equities
Sign up to see every warm intro you have to InnoCom Bio Equities
- Paths you didn't know you had: your email and LinkedIn already hold routes to the InnoCom Bio Equities team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
InnoCom Bio Equities positions itself as a manager of life science special purpose vehicles, giving investors exposure to a portfolio of multiple innovative life sciences technologies rather than a single bet. Its approach centers on providing seed capital to innovators and founders, diversifying risk through portfolio investment, and creating synergies by securing multiple technologies. The firm emphasizes early commercialization opportunities, expedited value creation for founders, and exclusive intellectual property arrangements that include royalties and out-licensing. The model is built to spread risk across several technologies while supporting the path from innovation to commercialization in the life sciences sector.
Source: firm website, verified Oct 17, 2026.
Team · 8 people
from the firm's website
Co-founder of InnoCom Bio Equities and managing member of Metro Pacific BDS. Finance executive with prior roles as managing director for finance at Esperance Private Equity, CFO at Granny Goose Foods, and leadership positions across several companies.
Veterinarian (DVM, MRCVS) and co-founder of InnoCom Bio Equities. Founder and CEO of Veterinary Health Research Centers, established eight certified US animal health hospitals, and has held executive roles at leading contract research organizations.
Veterinarian (DVM) and co-founder of InnoCom Bio Equities. Founder of Pacific AgVet and proprietor of Pacific AH Consulting, with co-founding roles at Kiah Bio, Sprint Health, and Bilby BioPure.
Managing director for affiliations and co-founder of 3I'SVIEW and Beaute Innovations. Background spans senior sales, SAP consulting, and finance/capital markets roles across numerous companies.
Scientific and business advisory board member. Executive director at Phoenix Biotechnology with 28 years in life sciences, including product launch and field direction work at UCB, Daiichi Sankyo, and Abbott (notably Humira).
Business advisory board member. CEO and co-founder of Fintegrate Consulting and managing partner at Transatlantic Partners Group, with 20 years of management consulting helping Swiss companies expand into the US.
Business advisory board member. Managing director at Excel Venture Management and Harvard professor, having managed a $225M fund invested in 40+ life science companies and founded or led several NASDAQ-listed biotech firms.
Scientific advisory board member. COO and co-founder of Menten AI (Y Combinator W20), with a bioinformatics background including postdoctoral research at KTH Royal Institute of Technology and a visiting scholar role at Caltech.
Investments · 11 tracked
founders shown can be your intro pathOther
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Anti-Microbe SolutionAntibiotic Resistant Infection Management & Wound CareBiopharmaceutical ProductionDamaged Lung TherapeuticsHeart FailureHeart Failure (Restrictive Cardiomyopathy)Large Burn and Blast Skin ReplacementLive-Attenuated Replication-Competent Herpes SolutionOvarian & Esophageal CancersSmall-molecule Anti-cancer TherapeuticTemporary Blood Substitute
Frequently asked questions
- How many investments has InnoCom Bio Equities made?
- InnoCom Bio Equities has 11 tracked investments.
- What stage does InnoCom Bio Equities invest at?
- InnoCom Bio Equities invests at the Seed stage.
- What sectors does InnoCom Bio Equities focus on?
- InnoCom Bio Equities focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is InnoCom Bio Equities located?
- InnoCom Bio Equities is headquartered in San Francisco, US.
Images
Similar investors
BOLD Capital Partners is a venture capital firm backing entrepreneurs and companies working on emerging science and technologies aimed at disrupting large markets and solving major human challenges.
Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.
Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.
Mystic Ventures is a rolling fund that backs CNS and neurotherapeutic companies, focusing on psychedelic and neuroplastogen medicines and the clinical infrastructure to deliver them.
Selvedge Venture is an impact-focused investor backing founders and startups developing deep technology in life sciences and healthcare aimed at alleviating the burden of age-related medical conditions.